Digna Biotech Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Digna Biotech General Information

Description

Developer of therapeutic and diagnostic products designed to offer treatment of acute hospital cases. The company's therapeutic and diagnostic products leverages world-class scientific and clinical expertise to turn early-stage medical innovations into clinical-stage partnering candidates for further development and subsequent commercialization.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Avda. Pio XII, 22
  • Oficina 2
  • 31008 Pamplona
  • Spain
+34 948
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Avda. Pio XII, 22
  • Oficina 2
  • 31008 Pamplona
  • Spain
+34 948

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Digna Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Jul-2016 Completed Out of Business
3. Grant 03-Feb-2011 Completed Generating Revenue
2. Early Stage VC 26-Sep-2008 $4.32M $4.32M Completed Startup
1. Early Stage VC 23-Oct-2007 Completed Startup
To view Digna Biotech’s complete valuation and funding history, request access »

Digna Biotech Patents

Digna Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2014522879-A Use of cardiotrophin-1 for the treatment of kidney disease Pending 10-Aug-2011
AU-2012293574-A1 Use of cardiotrophin-1 for the treatment of kidney diseases Inactive 10-Aug-2011
CA-2844792-A1 Use of cardiotrophin-1 for the treatment of kidney diseases Inactive 10-Aug-2011
EP-2742948-A1 Use of cardiotrophin-1 for the treatment of kidney diseases Inactive 10-Aug-2011
US-20140170125-A1 Use of cardiotrophin-1 for the treatment of kidney diseases Inactive 10-Aug-2011 A61K38/22
To view Digna Biotech’s complete patent history, request access »

Digna Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Digna Biotech Investments (2)

Digna Biotech’s most recent deal was a Early Stage VC with Formune for . The deal was made on 19-Sep-2012.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Formune 19-Sep-2012 Early Stage VC Drug Discovery
Hepacyl Therapeutics 01-May-2010 Joint Venture Biotechnology
To view Digna Biotech’s complete investments history, request access »

Digna Biotech FAQs

  • When was Digna Biotech founded?

    Digna Biotech was founded in 2003.

  • Where is Digna Biotech headquartered?

    Digna Biotech is headquartered in Pamplona, Spain.

  • What is the size of Digna Biotech?

    Digna Biotech has 11 total employees.

  • What industry is Digna Biotech in?

    Digna Biotech’s primary industry is Diagnostic Equipment.

  • Is Digna Biotech a private or public company?

    Digna Biotech is a Private company.

  • What is Digna Biotech’s current revenue?

    The current revenue for Digna Biotech is .

  • How much funding has Digna Biotech raised over time?

    Digna Biotech has raised $4.32M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process